Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 166.81M P/E - EPS this Y 41.10% Ern Qtrly Grth -
Income -111.08M Forward P/E -2.62 EPS next Y 41.10% 50D Avg Chg -1.00%
Sales 11M PEG 0.00 EPS past 5Y - 200D Avg Chg -58.00%
Dividend N/A Price/Book 1.22 EPS next 5Y 110.70% 52W High Chg -76.00%
Recommedations 3.00 Quick Ratio 4.20 Shares Outstanding 54.85M 52W Low Chg 20.00%
Insider Own 15.75% ROA -63.43% Shares Float 46.78M Beta 0.70
Inst Own 32.74% ROE -184.32% Shares Shorted/Prior 1.21M/1.46M Price 3.09
Gross Margin - Profit Margin - Avg. Volume 1,429,196 Target Price 1.00
Oper. Margin -1,636.13% Earnings Date Nov 11 Volume 386,952 Change -1.59%
About Cara Therapeutics, Inc.

Cara Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on developing and commercializing therapeutics treatment of chronic pruritus in the United States. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. It also develops Oral difelikefalin, which is in Phase II/III clinical trial to treat chronic pruritus with notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; Vifor Fresenius Medical Care Renal Pharma Ltd. development and commercialization of KORSUVA injection for the treatment of moderate-to-severe pruritus in adult patients undergoing hemodialysis; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut.

Cara Therapeutics, Inc. News
11/17/24 Cara Therapeutics Third Quarter 2024 Earnings: Beats Expectations
11/14/24 Cara: Q3 Earnings Snapshot
08/15/24 Cara: Q2 Earnings Snapshot
07/11/24 Cara Therapeutics Announces Exploration of Strategic Alternatives
06/13/24 Chipotle, McDonald's initiated: Wall Street's top analyst calls
06/12/24 Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
05/13/24 Cara Therapeutics (CARA) Reports Q1 Loss, Misses Revenue Estimates
05/13/24 Cara Therapeutics Reports First Quarter 2024 Financial Results
05/06/24 Cara Therapeutics to Announce First Quarter 2024 Financial Results on May 13, 2024
04/02/24 Cara Therapeutics to Present at the 23rd Annual Needham Virtual Healthcare Conference
03/07/24 Cara Therapeutics to Host Notalgia Paresthetica (NP) Virtual KOL Event on Wednesday, March 27, 2024
03/07/24 7 F-Rated Stocks to Sell in March 2024
03/07/24 Analysts Have Made A Financial Statement On Cara Therapeutics, Inc.'s (NASDAQ:CARA) Yearly Report
03/06/24 Cara Therapeutics Full Year 2023 Earnings: Misses Expectations
03/05/24 Cara Therapeutics, Inc. (NASDAQ:CARA) Q4 2023 Earnings Call Transcript
03/05/24 Q4 2023 Cara Therapeutics Inc Earnings Call
03/04/24 Cara Therapeutics (CARA) Reports Q4 Loss, Tops Revenue Estimates
03/04/24 Cara Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results
10:05 AM We're A Little Worried About Cara Therapeutics' (NASDAQ:CARA) Cash Burn Rate
02/12/24 Cara Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
CARA Chatroom

User Image lonedaddy Posted - 3 hours ago

$CARA Assuming they are working a deal with CSL. any speculation on whether CSL will buy them outright and what possible price? I doubt CARA board would just sell for cash value. In the new Administration with Dr. Oz is there a chance Korsuva gets bundled in now? And what is it worth to CSL Worldwide? Other options could be a merger with CARA holders getting CSL stock. So potentially what might the value be? 100 mil? 200 mil? More? Yes we know this is garbage the way it was run but in more competent hands and a less corrupt FDA what might be different.

User Image RETAlerts Posted - 1 day ago

$CARA at 0.319 is starting to show some signs of a stronger breakout, we can see a couple of zones ahead that need to be broken, now up 10% since our first mention. (15 minute delay)

User Image d_risk Posted - 6 days ago

$CARA - Cara Therapeutics, Inc. - 10Q - Updated Risk Factors Updated financials show reduced losses but increased deficit; new risks in employee matters and growth management; heightened Nasdaq delisting risk due to equity non-compliance. #Risk @caratherapinc https://d-risk.ai/CARA/10-Q/2024-11-14

User Image liadanielle Posted - 1 week ago

$CARA Arqt. This week!!

User Image Buckwacker Posted - 1 week ago

$CARA your pipeline sucks…. 🤦‍♂️

User Image nick30017 Posted - 1 week ago

$CARA is Earnings on the 11th monday?

User Image liadanielle Posted - 1 week ago

$CARA Drop this pig. I made money off this 4 years ago!!! Move on to ARQT. You can thank me later

User Image Stoxkcs Posted - 1 week ago

Holding $CARA in my long-term portfolio

User Image PenkeTrading Posted - 1 week ago

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Cara Therapeutic. Is that bullish or bearish? $CARA #RsiOverbought #NASDAQ

User Image Estimize Posted - 1 week ago

Wall St is expecting -0.24 EPS for $CARA Q3 [Reporting 11/11 AMC] http://www.estimize.com/intro/cara?chart=historical&metric_name=eps&utm_c

User Image KnotzInvestments Posted - 2 weeks ago

$CARA THIS ONE IS ABOUT TO PUMP

User Image OffComesTheShirt Posted - 2 weeks ago

$CARA 10% Off Comes The Shirt.

User Image Stoxkcs Posted - 2 weeks ago

$CARA with a beautiful chart and with earnings coming next week. Good News will send this

User Image lasmanoz Posted - 2 weeks ago

$CARA just bought 1 share :)

User Image CarolaT Posted - 2 weeks ago

$CARA In..

User Image joe77w Posted - 2 weeks ago

$CARA CSL engages in discussions with Cara, Csl owns 13.5% os, Csl Is the commercial partner https://uk.marketscreener.com/quote/stock/CARA-THERAPEUTICS-INC-15672075/news/CSL-Limited-Engages-in-Discussions-with-Cara-Therapeutics-48241368/

User Image joe77w Posted - 2 weeks ago

$CARA pending asset sale and/or buyout according Press release, co owns 55 mln USD in cash and seeking strategic alternative review, any day by now we should get some news 1 USD per share in cash

User Image Stockboi_ Posted - 2 weeks ago

$gpro $cldi $cara watching all Had $ocgn on the list as well but it already took off

User Image PapaRoki Posted - 2 weeks ago

$CARA

User Image joe77w Posted - 2 weeks ago

$CARA maybe news coming, Csl potentially interested in buying significant material assets from Cara 50 cents/1 USD ? Do your due diligence before investing your Money

User Image TellMeEverythingUKnow Posted - 2 weeks ago

$CARA Watching this one for a possible move to .42 - .52. Recently had a double bottom on the daily, 100% move from the recent low would be roughly .50 Cents. No volume to speak of right now.

User Image joe77w Posted - 2 weeks ago

$CARA CSL owns 13.5% in Cara

User Image joe77w Posted - 2 weeks ago

$CARA huge news imo

User Image joe77w Posted - 2 weeks ago

$CARA OVERLOOKED news about Cara, in talks to sell assets to shareholder and partner CSL VIFOR https://uk.marketscreener.com/quote/stock/CARA-THERAPEUTICS-INC-15672075/news/CSL-Limited-Engages-in-Discussions-with-Cara-Therapeutics-48241368/

User Image commonvariablesxyz Posted - 2 weeks ago

$cara 1

User Image DARKP00L Posted - 2 weeks ago

$CARA this stock is seeing a surge in interest. Market volatility might ensue!

User Image Stoxkcs Posted - 2 weeks ago

$CARA has their earnings report November 11th . I'm buying more regardless because it's in my long-term portfolio

User Image lasmanoz Posted - 2 weeks ago

$CARA $15 soon

User Image Iamthecooler Posted - 2 weeks ago

$CARA sold all for tax loss, prepare for it to go parabolic 100+ now. FML

User Image StockCrushing Posted - 10/31/24

$TVGN $CARA $ATHA Are the stocks I’m holding like the risk reward potential on these let’s see what happens 💸💸💸

Analyst Ratings
Canaccord Genuity Hold Jun 13, 24
HC Wainwright & Co. Neutral Jun 13, 24
Needham Hold Jun 13, 24
Needham Buy May 23, 24
HC Wainwright & Co. Buy May 15, 24
Needham Buy May 14, 24
Needham Buy Apr 10, 24
Canaccord Genuity Buy Mar 6, 24
Needham Buy Mar 5, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Posner Christopher President and CEO President and CEO Aug 03 Sell 3.07 4,307 13,222 168,207 08/04/23
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Apr 04 Sell 4.91 2,481 12,182 91,046 04/06/23
Goncalves Joana Chief Medical Office.. Chief Medical Officer Apr 04 Sell 4.91 2,481 12,182 56,404 04/06/23
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Apr 04 Sell 4.91 2,733 13,419 156,740 04/06/23
Posner Christopher President and CEO President and CEO Feb 02 Sell 11.80 4,191 49,454 182,370 02/03/23
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Dec 21 Sell 11.27 3,506 39,513 166,275 12/23/22
Goncalves Joana Chief Medical Office.. Chief Medical Officer Dec 21 Sell 11.27 2,992 33,720 71,901 12/23/22
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Dec 21 Sell 11.27 2,561 28,862 99,783 12/23/22
Ives Jeffrey L. Director Director Jul 15 Sell 9.05 3,600 32,580 15,476 07/19/22
BAINS HARRISON M JR Director Director Jul 15 Sell 9.05 7,200 65,160 25,076 07/19/22
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Apr 01 Sell 11.91 1,642 19,556 102,344 04/05/22
Goncalves Joana Chief Medical Office.. Chief Medical Officer Apr 01 Sell 11.91 1,642 19,556 74,893 04/05/22
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Apr 01 Sell 11.91 1,784 21,247 169,781 04/05/22
Posner Christopher President and CEO President and CEO Apr 04 Sell 12.67 2,006 25,416 201,031 04/05/22
Reilly Thomas Charles Chief Financial Offi.. Chief Financial Officer Mar 03 Sell 11.38 2,044 23,261 37,811 03/04/22
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Mar 03 Sell 11.38 1,787 20,336 103,986 03/04/22
Posner Christopher Director Director Jun 07 Sell 13.04 2,304 30,044 16,096 06/07/21
Ives Jeffrey L. Director Director Jun 07 Sell 13.05 2,520 32,886 15,380 06/07/21
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Mar 08 Sell 17.98 3,358 60,377 119,319 03/08/21
CHALMERS DEREK T President & CEO President & CEO Mar 08 Sell 17.98 3,103 55,792 950,511 03/08/21
Terrillion Scott Sec'y; Chief Complia.. Sec'y; Chief Compliance & G.C. Feb 25 Sell 19.33 4,004 77,397 44,432 02/25/21
Menzaghi Frederique Ph.D. Chief Scientific Off.. Chief Scientific Off,SVP-R&D Feb 25 Sell 19.33 5,003 96,708 112,677 02/25/21
Goncalves Joana Chief Medical Office.. Chief Medical Officer Feb 25 Sell 19.33 3,372 65,181 26,703 02/25/21
CHALMERS DEREK T President & CEO President & CEO Feb 25 Sell 19.33 11,729 226,722 943,614 02/25/21
CHALMERS DEREK T President & CEO President & CEO Dec 29 Sell 16 5,000 80,000 942,671 12/29/20